Table 1 Baseline characteristics of patients at entry into the study
Group A (n = 40) | Group B (MI-E) (n = 35) | P | |
|---|---|---|---|
Age (years) | 62 ± 19.2 | 61.4 ± 15.1 | NS |
Sex (M/F) | 21/19 | 28/7 | NS |
SAPS II | 47.8 ± 17.7 | 45 ± 15 | NS |
Duration of MV (days) | 9.4 ± 4.8 | 10.5 ± 4.1 | NS |
Patients with chronic pulmonary disorders (n, %) | 9 (23%) | 7 (20%) | NS |
Patients with hypoxemic respiratory failure (n,%) | 24 (60%) | 18 (52%) | NS |
Reasons for MV (n) | |||
COPD exacerbations | 6 | 4 | |
Congestive heart failure | 5 | 4 | |
Community-acquired pneumonia | 11 | 6 | |
Hospital-acquired pneumonia | - | 2 | |
Postoperative respiratory failure | 5 | 8 | |
Acute lung injury | - | 1 | |
Thoracic trauma | 6 | 3 | |
Sepsis | 7 | 4 | |
Cardiac arrest | - | 3 |